CAS RN: 19984-46-4

1-(1-ADAMANTYL)PIPERAZINE

Product Availability

Choose a grade to view its available package options.

3 package records0 with current stock2 grade groups
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250419 1g Out of stock Inquiry
Batchno.20260527 5g Out of stock Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250325 1g Out of stock 15 business days Inquiry
  • Product code: starshine_CAS19984-46-4
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

19984-46-4 / 1-(1-adamantyl)piperazine

Standard CAS: 19984-46-4 Multi CAS: No

Basic Information

CAS
19984-46-4
Multi CAS
No
Molecular Formula
C14H24N2
Molecular Weight
220.350000
Exact Mass
220.193949
SMILES
C1CN(CCN1)C23CC4CC(C2)CC(C4)C3
InChI
InChI=1S/C14H24N2/c1-3-16(4-2-15-1)14-8-11-5-12(9-14)7-13(6-11)10-14/h11-13,15H,1-10H2
InChIKey
DXYGTOJPNHDXRM-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
16
Fraction Csp3
1
Rotatable bonds
1
H-bond acceptors
2
H-bond donors
1
Molar refractivity
65.35
TPSA
15.27

LogP / Solubility

WLOGP
1.86
MLOGP
1.64
XLogP3
2.3
Consensus LogP
1.93
Log S (ESOL)
-2.31
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.71
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.76
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.74

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
6.5

Safety & Transport

Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal] H332 (100%): Harmful if inhaled [Warning Acute toxicity, inhalation]
Precautionary Statement Codes
P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501

Get In Touch

Contact Us